# A Study of HL40626S Tablets in Healthy Adults

> **NCT07736586** · PHASE1 · NOT_YET_RECRUITING · sponsor: **HighsLab Therapeutics Inc.** · enrollment: 64 (estimated)

## Conditions studied

- Psoriasis (PsO)
- Skin Disease
- Immune System Disease
- Skin Diseases, Papulosquamous

## Interventions

- **DRUG:** HL40626S tablets
- **DRUG:** HL40626S placebo

## Key facts

- **NCT ID:** NCT07736586
- **Lead sponsor:** HighsLab Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-02
- **Final completion:** 2027-05
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07736586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07736586, "A Study of HL40626S Tablets in Healthy Adults". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07736586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*